Tandem Diabetes Care Stock Price History

TNDM Stock  USD 30.63  0.59  1.89%   
Below is the normalized historical share price chart for Tandem Diabetes Care extending back to November 14, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tandem Diabetes stands at 30.63, as last reported on the 1st of December, with the highest price reaching 31.76 and the lowest price hitting 30.56 during the day.
IPO Date
14th of November 2013
200 Day MA
38.2867
50 Day MA
35.1442
Beta
1.367
 
Yuan Drop
 
Covid
If you're considering investing in Tandem Stock, it is important to understand the factors that can impact its price. Tandem Diabetes Care owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Tandem Diabetes Care exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tandem Diabetes' Variance of 9.63, coefficient of variation of (605.36), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide.
  
At this time, Tandem Diabetes' Common Stock Shares Outstanding is very stable compared to the past year. As of the 1st of December 2024, Liabilities And Stockholders Equity is likely to grow to about 1 B, while Common Stock Total Equity is likely to drop about 71 K. . As of the 1st of December 2024, Price To Sales Ratio is likely to drop to 2.44. In addition to that, Price Earnings Ratio is likely to grow to -8.19. Tandem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1396

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTNDM

Estimated Market Risk

 3.12
  actual daily
27
73% of assets are more volatile

Expected Return

 -0.44
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.14
  actual daily
0
Most of other assets perform better
Based on monthly moving average Tandem Diabetes is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tandem Diabetes by adding Tandem Diabetes to a well-diversified portfolio.
Price Book
8.4627
Enterprise Value Ebitda
(10.72)
Price Sales
2.4
Shares Float
65.1 M
Wall Street Target Price
51.25

Tandem Diabetes Stock Price History Chart

There are several ways to analyze Tandem Stock price data. The simplest method is using a basic Tandem candlestick price chart, which shows Tandem Diabetes price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 24, 202445.44
Lowest PriceNovember 15, 202427.34

Tandem Diabetes December 1, 2024 Stock Price Synopsis

Various analyses of Tandem Diabetes' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tandem Stock. It can be used to describe the percentage change in the price of Tandem Diabetes from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tandem Stock.
Tandem Diabetes Price Action Indicator(0.83)
Tandem Diabetes Price Daily Balance Of Power(0.49)
Tandem Diabetes Price Rate Of Daily Change 0.98 

Tandem Diabetes December 1, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Tandem Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Tandem Diabetes intraday prices and daily technical indicators to check the level of noise trading in Tandem Stock and then apply it to test your longer-term investment strategies against Tandem.

Tandem Stock Price History Data

The price series of Tandem Diabetes for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 18.1 with a coefficient of variation of 15.34. The price distribution for the period has arithmetic mean of 37.03. The median price for the last 90 days is 37.36. The company completed stock split (1:10) on 10th of October 2017. Tandem Diabetes Care had dividends distributed to its stock-holders on 2017-10-10.
OpenHighLowCloseVolume
12/01/2024
 31.41  31.76  30.56  30.63 
11/29/2024 31.41  31.76  30.56  30.63  446,552 
11/27/2024 30.32  31.32  30.31  31.22  824,549 
11/26/2024 30.35  31.07  29.99  30.04  1,311,516 
11/25/2024 30.81  31.12  30.18  30.42  1,325,033 
11/22/2024 30.75  31.26  30.00  30.81  1,228,017 
11/21/2024 30.71  32.38  30.34  30.74  1,881,418 
11/20/2024 28.03  30.33  27.40  30.15  2,057,374 
11/19/2024 28.50  28.60  27.66  27.87  1,344,291 
11/18/2024 27.15  29.27  27.15  28.76  1,437,982 
11/15/2024 28.94  28.94  27.28  27.34  1,684,031 
11/14/2024 29.63  30.22  28.45  28.59  2,158,340 
11/13/2024 31.44  31.57  29.31  29.67  1,429,654 
11/12/2024 30.75  31.76  30.28  31.10  1,311,416 
11/11/2024 31.10  31.99  30.76  31.37  1,938,741 
11/08/2024 33.71  33.97  29.90  30.60  3,313,917 
11/07/2024 32.60  34.55  32.00  33.32  3,585,204 
11/06/2024 34.80  35.50  32.65  34.24  3,165,392 
11/05/2024 32.72  33.88  32.66  33.11  1,040,983 
11/04/2024 31.28  33.20  31.28  32.85  1,414,829 
11/01/2024 31.69  32.13  31.10  31.91  906,252 
10/31/2024 32.31  32.52  31.32  31.37  760,502 
10/30/2024 32.50  32.99  32.16  32.36  782,411 
10/29/2024 32.51  32.96  31.91  32.93  1,272,846 
10/28/2024 31.79  33.12  31.49  32.75  1,554,369 
10/25/2024 31.86  32.19  30.68  31.35  1,075,433 
10/24/2024 32.50  32.93  31.48  31.76  967,661 
10/23/2024 33.46  33.68  31.86  32.15  2,343,128 
10/22/2024 34.38  34.60  33.17  33.54  908,479 
10/21/2024 35.17  35.84  33.73  34.11  1,204,219 
10/18/2024 35.15  36.11  34.90  35.34  1,245,435 
10/17/2024 37.27  37.64  34.09  34.81  1,817,704 
10/16/2024 37.80  38.00  37.31  37.50  739,996 
10/15/2024 36.98  38.11  36.98  37.61  880,043 
10/14/2024 37.51  38.94  36.67  37.36  1,185,116 
10/11/2024 36.05  37.35  35.66  37.07  1,624,434 
10/10/2024 38.75  38.75  35.16  36.14  3,382,275 
10/09/2024 39.52  39.98  38.88  39.12  804,067 
10/08/2024 41.92  42.70  39.85  39.87  809,490 
10/07/2024 41.59  42.35  40.85  41.78  701,197 
10/04/2024 40.47  41.88  39.64  41.78  906,403 
10/03/2024 41.05  41.71  39.91  40.46  658,860 
10/02/2024 42.39  42.39  40.58  41.17  967,267 
10/01/2024 41.85  42.42  39.92  41.07  1,608,635 
09/30/2024 42.25  43.21  41.39  42.41  1,190,889 
09/27/2024 44.04  45.28  42.44  42.45  1,354,191 
09/26/2024 44.51  45.03  42.59  44.08  1,431,715 
09/25/2024 45.47  47.60  42.50  44.64  2,428,800 
09/24/2024 45.04  46.36  44.76  45.44  807,058 
09/23/2024 45.17  46.68  44.21  45.42  1,652,319 
09/20/2024 44.55  45.98  43.17  44.63  1,851,392 
09/19/2024 44.29  44.58  43.42  44.45  939,629 
09/18/2024 42.70  44.49  42.39  42.64  792,180 
09/17/2024 42.65  44.82  42.04  43.06  944,324 
09/16/2024 43.71  44.53  42.66  42.70  965,038 
09/13/2024 44.01  45.40  43.76  43.97  994,806 
09/12/2024 42.75  45.10  42.75  43.76  1,205,219 
09/11/2024 40.70  43.09  40.04  42.73  1,134,890 
09/10/2024 42.25  42.49  39.58  41.00  878,546 
09/09/2024 43.29  43.66  41.90  42.24  824,538 
09/06/2024 42.85  43.46  41.13  42.40  1,101,390 

About Tandem Diabetes Stock history

Tandem Diabetes investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tandem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tandem Diabetes Care will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tandem Diabetes stock prices may prove useful in developing a viable investing in Tandem Diabetes
Last ReportedProjected for Next Year
Common Stock Shares Outstanding65 M68.2 M
Net Loss-108.8 M-114.2 M

Tandem Diabetes Quarterly Net Working Capital

492.78 Million

Tandem Diabetes Stock Technical Analysis

Tandem Diabetes technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tandem Diabetes technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tandem Diabetes trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Tandem Diabetes Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Tandem Diabetes' price direction in advance. Along with the technical and fundamental analysis of Tandem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tandem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.37)
Earnings Share
(1.94)
Revenue Per Share
13.082
Quarterly Revenue Growth
0.314
Return On Assets
(0.1)
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.